PubRank

Thomas D Schiano

Author PubWeight™ 52.82‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Increased prevalence of primary biliary cirrhosis near Superfund toxic waste sites. Hepatology 2006 2.08
2 TIPS for refractory ascites: a 6-year single-center experience with expanded polytetrafluoroethylene-covered stent-grafts. AJR Am J Roentgenol 2015 1.99
3 Posttransplant plasma cell hepatitis (de novo autoimmune hepatitis) is a variant of rejection and may lead to a negative outcome in patients with hepatitis C virus. Liver Transpl 2008 1.68
4 Survival and risk of recidivism in methadone-dependent patients undergoing liver transplantation. Am J Transplant 2003 1.60
5 De novo hepatocellular carcinoma occurring in a transplanted liver: case report and review of the literature. Dig Dis Sci 2006 1.45
6 Diabetes mellitus and advanced liver fibrosis are risk factors for severe anaemia during telaprevir-based triple therapy. Liver Int 2013 1.43
7 Sequential presentation of primary biliary cirrhosis and autoimmune hepatitis. Eur J Gastroenterol Hepatol 2014 1.40
8 A randomized, open-label study to evaluate the safety and pharmacokinetics of human hepatitis C immune globulin (Civacir) in liver transplant recipients. Liver Transpl 2005 1.13
9 Early and late outcome of cardiac surgery in patients with liver cirrhosis. Liver Transpl 2007 1.08
10 Costs of telaprevir-based triple therapy for hepatitis C: $189,000 per sustained virological response. Hepatology 2014 1.05
11 Prevalence of nonalcoholic fatty liver disease in women with polycystic ovary syndrome. Clin Gastroenterol Hepatol 2007 1.03
12 Risk for immune-mediated graft dysfunction in liver transplant recipients with recurrent HCV infection treated with pegylated interferon. Gastroenterology 2012 1.01
13 Treatment of chest pain in patients with noncardiac, nonreflux, nonachalasia spastic esophageal motor disorders using botulinum toxin injection into the gastroesophageal junction. Am J Gastroenterol 2002 0.95
14 Outcome analysis of cirrhotic patients undergoing chest tube placement. Chest 2004 0.94
15 Influenza vaccination in orthotopic liver transplant recipients: absence of post administration ALT elevation. Am J Transplant 2004 0.91
16 Pegylated interferon-induced immune-mediated hepatitis post-liver transplantation. Liver Transpl 2006 0.90
17 Plasma cell hepatitis in hepatitis C virus patients post-liver transplantation: case-control study showing poor outcome and predictive features in the liver explant. Liver Transpl 2009 0.90
18 Intranasal desmopressin versus blood transfusion in cirrhotic patients with coagulopathy undergoing dental extraction: a randomized controlled trial. J Oral Maxillofac Surg 2010 0.88
19 Medication level variability index predicts rejection, possibly due to nonadherence, in adult liver transplant recipients. Liver Transpl 2014 0.87
20 Hepatocellular carcinoma arising in a pigmented telangiectatic adenoma with nuclear β-catenin and glutamine synthetase positivity: case report and review of the literature. Am J Surg Pathol 2011 0.87
21 Impact of donor age on survival and fibrosis progression in patients with hepatitis C undergoing liver transplantation using HCV+ allografts. Liver Transpl 2006 0.87
22 Plasma cell hepatitis (de-novo autoimmune hepatitis) developing post liver transplantation. Curr Opin Organ Transplant 2012 0.84
23 Obliterative portal venopathy: a clinical and histopathological review. Dig Dis Sci 2013 0.84
24 Marked Differences in acute cellular rejection rates between living-donor and deceased-donor liver transplant recipients. Transplantation 2005 0.83
25 Right hepatectomy for living donation: role of remnant liver volume in predicting hepatic dysfunction and complications. Surgery 2013 0.83
26 Mercaptopurine-induced hepatoportal sclerosis in a patient with Crohn's disease. J Crohns Colitis 2012 0.83
27 Increasing hepatic arteriole wall thickness and decreased luminal diameter occur with increasing age in normal livers. J Hepatol 2011 0.82
28 The management of hospitalized patients with cirrhosis: the Mount Sinai experience and a guide for hospitalists. Dig Dis Sci 2011 0.82
29 Liver failure and need for liver transplantation in patients with advanced hepatoportal sclerosis. Am J Surg Pathol 2007 0.82
30 Overdose with suicidal intent: ethical considerations for liver transplant programs. Liver Transpl 2011 0.82
31 Results of retransplantation for recurrent hepatitis C. Hepatology 2003 0.82
32 Recurrent hepatitis C after retransplantation: factors affecting graft and patient outcome. Liver Transpl 2005 0.82
33 Tumors with intrahepatic bile duct differentiation in cirrhosis: implications on outcomes after liver transplantation. Transplantation 2015 0.82
34 Hepatoportal sclerosis: CT and MRI appearance with histopathologic correlation. AJR Am J Roentgenol 2012 0.81
35 Diagnosis of 6 mercaptopurine hepatotoxicity post liver transplantation utilizing metabolite assays. Am J Transplant 2004 0.81
36 Chronic ductopenic rejection in patients with recurrent hepatitis C virus treated with pegylated interferon alfa-2a and ribavirin. Transplantation 2007 0.79
37 Hemophagocytic syndrome occurring in an adult liver transplant recipient having Still's disease. Hepatol Int 2010 0.78
38 Adult live donor liver transplantation. Clin Liver Dis 2005 0.78
39 Cross-genotypic polyclonal anti-HCV antibodies from human ascitic fluid. J Virol Methods 2010 0.78
40 An escalating dose regimen of pegylated interferon and ribavirin in HCV cirrhotic patients referred for liver transplant. Transplantation 2009 0.78
41 Use of splenic artery embolization to relieve tense ascites following liver transplantation in a patient with paroxysmal nocturnal hemoglobinuria. Liver Transpl 2007 0.78
42 Quantification of hepatic blood flow using a high-resolution phase-contrast MRI sequence with compressed sensing acceleration. AJR Am J Roentgenol 2015 0.77
43 Syngeneic living-donor liver transplantation without the use of immunosuppression. Gastroenterology 2002 0.77
44 Treating chronic hepatitis C in the primary care setting. Semin Liver Dis 2005 0.77
45 Acute cellular rejection resulting in sinusoidal obstruction syndrome and ascites postliver transplantation. Transplantation 2011 0.77
46 Rapid reversal of parenteral-nutrition-associated cirrhosis following isolated intestinal transplantation. J Gastrointest Surg 2009 0.77
47 Histopathology and clinical correlates of end-stage hepatitis B cirrhosis: a possible mechanism to explain the response to antiviral therapy. Liver Transpl 2005 0.76
48 Long-term care of the liver transplant recipient. Clin Liver Dis 2007 0.76
49 Domino liver transplantation: a practical option in the face of the organ shortage. Prog Transplant 2003 0.76
50 Hepatocellular proliferation and changes in microarchitecture of right lobe allografts in adult transplant recipients. Liver Transpl 2004 0.76
51 To B(iopsy) or not to B(iopsy) …. Clin Gastroenterol Hepatol 2010 0.75
52 Diagnostic difficulties, therapeutic strategies, and performance of scoring systems in patients with autoimmune hepatitis and concurrent hepatitis B/C. Scand J Gastroenterol 2013 0.75
53 A new approach for treatment of hepatitis C in hepatitis C-autoimmune hepatitis overlap syndrome. Gastroenterol Hepatol (N Y) 2010 0.75
54 Rapidly progressive recurrent hepatitis C virus infection starting 9 days after liver transplantation. Liver Transpl 2007 0.75
55 Clearance of Hepatic Sphingomyelin by Olipudase Alfa Is Associated With Improvement in Lipid Profiles in Acid Sphingomyelinase Deficiency. Am J Surg Pathol 2016 0.75
56 Vitamin D status of human immunodeficiency virus-positive patients with advanced liver disease enrolled in the solid organ transplantation in HIV: multi-site study. Liver Transpl 2013 0.75
57 Recurrence of primary biliary cirrhosis and development of autoimmune hepatitis after liver transplant: A blind histologic study. Hepatol Res 2009 0.75
58 Still disease and the liver-an underappreciated association. Gastroenterol Hepatol (N Y) 2011 0.75
59 Long-term outcome after liver transplantation. Mt Sinai J Med 2012 0.75
60 Mucosal addressin cell adhesion molecule (MAdCAM-1) expression is upregulated in the cirrhotic liver and immunolocalises to the peribiliary plexus and lymphoid aggregates. Dig Dis Sci 2013 0.75
61 An association of myeloproliferative neoplasms and obliterative portal venopathy. Dig Dis Sci 2014 0.75
62 Exacerbation of sickle cell disease itself as a cause of abnormal liver chemistry tests. Dig Dis Sci 2006 0.75
63 Graft rejection occurring in post-liver transplant patients receiving cytotoxic chemotherapy: a case series. Liver Transpl 2009 0.75
64 Endoscopic diagnosis of bleeding Meckel's diverticulum in a multivisceral transplant recipient. Am J Transplant 2003 0.75
65 Regression of hepatic fibrosis after intestinal transplantation in total parenteral nutrition liver disease. Clin Gastroenterol Hepatol 2008 0.75
66 Lactulose: how many ways can one drug be prescribed? Am J Gastroenterol 2011 0.75
67 Therapeutic management of recurrent hepatitis C after liver transplantation. Liver Int 2007 0.75
68 Serum and ascites chromogranin-A in patients with metastatic neuroendocrine tumors. Pancreas 2011 0.75
69 Recurrent hepatitis C virus infection and outcome after living-donor liver transplant. Exp Clin Transplant 2013 0.75
70 Excellent results of cardiac surgery in patients with previous liver transplantation. Liver Transpl 2007 0.75
71 A morphometric study of the hepatic arterioles in end-stage primary sclerosing cholangitis. Virchows Arch 2014 0.75
72 Curricular guidelines for training in transplant hepatology. Liver Transpl 2002 0.75
73 Hepatitis C immune globulin (human) for the prevention of viral recurrence after liver transplantation. Expert Rev Clin Immunol 2007 0.75
74 Increased thickness of abdominal subcutaneous adipose tissue occurs more frequently in steatohepatitis than in simple steatosis. Arch Pathol Lab Med 2013 0.75
75 Waitlisted Candidates With Polycystic Liver Disease are More Likely to be Transplanted Than Those With Chronic Liver Failure. Transplantation 2017 0.75